Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.
| Dosage form | NDCs |
|---|---|
| liquid | 1 |
| solution | 1 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| natara global limited | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | BENZOIN | liquid | 66798-424DRUG FOR FURTHER PROCESSING |
| - | COAL TAR | solution | 66798-350DRUG FOR FURTHER PROCESSING |
Enquiry
Common questions
- Is NATARA GLOBAL LIMITED FDA approved?
- NATARA GLOBAL LIMITED holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does NATARA GLOBAL LIMITED make?
- 2 products are listed under NATARA GLOBAL LIMITED in the openFDA NDC Directory, most often as liquid; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.